Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!
Developing a reagent to replace traditional monoclonal antibodies.
Headlines from Mass High Tech about AXIOMX INC
Print this Listing
| Industry Classification | Biopharma/Biotechnology |
| Primary Business Focus | Biotechnology - Non-Pharmaceutical |
| Year Established | 2012 |
| Ownership Type | Private |
| Christopher McLeod | President/CEO | |||
| Michael Weiner | CSO/Founder | |||
| Tom Thompson | VP Sales/Marketing | email available to subscribers | ||
| Janet Verney | Executive Director | |||
| Dawn Alderman | Director Automation/Production | |||
| Margaret Kiss | Director Molecular Sciences |
* Downloads will not contain Personnel E-mail addresses
| Focus | Biotechnology - Non-Pharmaceutical |
| Location | Branford, CT |
| Website | http://www.axiomxinc.com |
| Revenue | Subscriber access only |
| Address | 688 E Main St Branford, CT, 06405 |
| Phone | 203-208-1918 |
| Subscriber access only | |
| Website | www.axiomxinc.com |
© 2012 American City Business Journals. All rights reserved. Use of this Site constitutes acceptance of our User Agreement (updated 3/14/12) and Privacy Policy (updated 3/14/12).
Your California Privacy Rights.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of American City Business Journals.